# Latvian Early Atherosclerosis Registry

> **NCT06393894** · — · RECRUITING · sponsor: **Pauls Stradins Clinical University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Coronary Artery Disease
- Atherosclerosis, Coronary

## Interventions

- **DIAGNOSTIC_TEST:** Near infrared spectroscopy
- **GENETIC:** Genetic testing for LDLR, APOB, PCSK9 and LDLRAP1 mutations and niR-126, -145 and -155 expression.

## Key facts

- **NCT ID:** NCT06393894
- **Lead sponsor:** Pauls Stradins Clinical University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-04-01
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06393894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06393894, "Latvian Early Atherosclerosis Registry". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06393894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*